272 related articles for article (PubMed ID: 14552880)
1. P38 MAP kinase is activated at early stages in Alzheimer's disease brain.
Sun A; Liu M; Nguyen XV; Bing G
Exp Neurol; 2003 Oct; 183(2):394-405. PubMed ID: 14552880
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
3. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
[TBL] [Abstract][Full Text] [Related]
4. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.
Hyman BT; Elvhage TE; Reiter J
Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
7. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
8. Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex.
Hoozemans JJ; Veerhuis R; Rozemuller AJ; Arendt T; Eikelenboom P
Neurobiol Dis; 2004 Apr; 15(3):492-9. PubMed ID: 15056456
[TBL] [Abstract][Full Text] [Related]
9. JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.
Zhu X; Ogawa O; Wang Y; Perry G; Smith MA
J Neurochem; 2003 Apr; 85(1):87-93. PubMed ID: 12641730
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
11. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
13. p38 kinase is activated in the Alzheimer's disease brain.
Hensley K; Floyd RA; Zheng NY; Nael R; Robinson KA; Nguyen X; Pye QN; Stewart CA; Geddes J; Markesbery WR; Patel E; Johnson GV; Bing G
J Neurochem; 1999 May; 72(5):2053-8. PubMed ID: 10217284
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of ubiquilin-1 in the human hippocampus: association with neurofibrillary tangle pathology.
Mizukami K; Abrahamson EE; Mi Z; Ishikawa M; Watanabe K; Kinoshita S; Asada T; Ikonomovic MD
Neuropathology; 2014 Feb; 34(1):11-8. PubMed ID: 23869942
[TBL] [Abstract][Full Text] [Related]
15. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.
Arendt T; Holzer M; Grossmann A; Zedlick D; Brückner MK
Neuroscience; 1995 Sep; 68(1):5-18. PubMed ID: 7477934
[TBL] [Abstract][Full Text] [Related]
16. Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: implications for MAP kinase activation in Alzheimer disease.
Knowles RB; Chin J; Ruff CT; Hyman BT
J Neuropathol Exp Neurol; 1999 Oct; 58(10):1090-8. PubMed ID: 10515232
[TBL] [Abstract][Full Text] [Related]
17. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
18. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.
Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T
Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease.
Pei JJ; Braak H; An WL; Winblad B; Cowburn RF; Iqbal K; Grundke-Iqbal I
Brain Res Mol Brain Res; 2002 Dec; 109(1-2):45-55. PubMed ID: 12531514
[TBL] [Abstract][Full Text] [Related]
20. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
